Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Lucid Diagnostics Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 19 | −4 |
| Shares | 1.92M | 1.77M | −147.4K (−7.7%) |
| Value | $2.60M | $2.49M | −$117.9K (−4.5%) |
New holders (1)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 15,545 | $22.0K | 0.00% |
Sold out (5)
Institutions that held Lucid Diagnostics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Kornitzer Capital Management Inc | 133,000 | $180.9K |
| Levin Capital Strategies, L.P. | 36,799 | $50.0K |
| Millennium Management LLC | 17,814 | $24.0K |
| Arcus Capital Partners, LLC | 3,100 | $4.22K |
| Bank of America Corp | 18 | $24 |